Nuvectis Pharma, Inc. (NVCT)
Nuvectis Pharma, Inc., a biopharmaceutical company, focuses on the development of precision medicines for the treatment of serious unmet medical needs in oncology. It develops NXP800, a novel heat shock factor 1 pathway inhibitor for the treatment of various cancers; and NXP900, a small molecule drug candidate to inhibit the Proto-oncogene c-Src and YES1 kinases. The company was incorporated in 2020 and is based in Fort Lee, New Jersey.
$124.97M
Mr. Ron Bentsur M.B.A.
8.00
Fort Lee, NJ
Feb 04, 2022
-5.19
$-1.29
3.14
3.17
514.56%
-5.33
-0.05
8.97
-30.25
3.17
-115.32%
-152.26%
Similar stocks (17)
Edgewise Therapeutics, Inc.
EWTX
Cullinan Oncology, Inc.
CGEM
Replimune Group, Inc.
REPL
Olema Pharmaceuticals, Inc.
OLMA
Celcuity Inc.
CELC
Eliem Therapeutics, Inc.
ELYM
C4 Therapeutics, Inc.
CCCC
Larimar Therapeutics, Inc.
LRMR
Monte Rosa Therapeutics, Inc.
GLUE
Compass Therapeutics, Inc.
CMPX
Gossamer Bio, Inc.
GOSS
Werewolf Therapeutics, Inc.
HOWL
Ikena Oncology, Inc.
IKNA
Kronos Bio, Inc.
KRON
Aerovate Therapeutics, Inc.
AVTE
Anebulo Pharmaceuticals, Inc.
ANEB
Lyra Therapeutics, Inc.
LYRA
ETF Exposure (11)
iShares Micro-Cap ETF
IWC
0.01514%
Vanguard Balanced Index Fund Institutional Shares
VBAIX
0%
Vanguard Balanced Index Fund Admiral Shares
VBIAX
0%
Vanguard Balanced Index Fund
VBINX
0%
Vanguard Extended Market Index Fund Institutional Shares
VIEIX
0%
Vanguard Institutional Total Stock Market Index Fund Institutional Shares
VITNX
0%
Vanguard Institutional Total Stock Market Index Fund
VITPX
0%
Vanguard Total Stock Market Index Fund
VITSX
0%
Vanguard Total Stock Market Index Fund
VTI
0%
Vanguard Total Stock Market Index Fund
VTSAX
0%
Vanguard Extended Market Index Fund
VXF
0%
Similar stocks (17)
Edgewise Therapeutics, Inc.
EWTX
Cullinan Oncology, Inc.
CGEM
Replimune Group, Inc.
REPL
Olema Pharmaceuticals, Inc.
OLMA
Celcuity Inc.
CELC
Eliem Therapeutics, Inc.
ELYM
C4 Therapeutics, Inc.
CCCC
Larimar Therapeutics, Inc.
LRMR
Monte Rosa Therapeutics, Inc.
GLUE
Compass Therapeutics, Inc.
CMPX
Gossamer Bio, Inc.
GOSS
Werewolf Therapeutics, Inc.
HOWL
Ikena Oncology, Inc.
IKNA
Kronos Bio, Inc.
KRON
Aerovate Therapeutics, Inc.
AVTE
Anebulo Pharmaceuticals, Inc.
ANEB
Lyra Therapeutics, Inc.
LYRA
ETF Exposure (11)
iShares Micro-Cap ETF
IWC
0.01514%
Vanguard Balanced Index Fund Institutional Shares
VBAIX
0%
Vanguard Balanced Index Fund Admiral Shares
VBIAX
0%
Vanguard Balanced Index Fund
VBINX
0%
Vanguard Extended Market Index Fund Institutional Shares
VIEIX
0%
Vanguard Institutional Total Stock Market Index Fund Institutional Shares
VITNX
0%
Vanguard Institutional Total Stock Market Index Fund
VITPX
0%
Vanguard Total Stock Market Index Fund
VITSX
0%
Vanguard Total Stock Market Index Fund
VTI
0%
Vanguard Total Stock Market Index Fund
VTSAX
0%
Vanguard Extended Market Index Fund
VXF
0%